Brief: Rani Therapeutics Holdings Inc Reports Quarterly Loss Per Share Of $0.33
Nov 10 (Reuters) - Rani Therapeutics Holdings Inc
RANI.O :
* RANI THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* RANI THERAPEUTICS HOLDINGS - CASH, CASH EQUIVALENTS,
RESTRICTED
CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF SEPTEMBER 30,
2022 TOTALED $98.7 MILLION
* QTRLY LOSS PER SHARE $0.33
* Q3 EARNINGS PER SHARE VIEW $-0.47 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6w46pY
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition